13 research outputs found
Genome-wide associations for birth weight and correlations with adult disease
Birth weight (BW) is influenced by both foetal and maternal factors and in observational studies is reproducibly associated with future risk of adult metabolic diseases including type 2 diabetes (T2D) and cardiovascular disease1. These lifecourse associations have often been attributed to the impact of an adverse early life environment. We performed a multi-ancestry genome-wide association study (GWAS) meta-analysis of BW in 153,781 individuals, identifying 60 loci where foetal genotype was associated with BW (P <5x10-8). Overall, ˜15% of variance in BW could be captured by assays of foetal genetic variation. Using genetic association alone, we found strong inverse genetic correlations between BW and systolic blood pressure (rg-0.22, P =5.5x10-13), T2D (rg-0.27, P =1.1x10-6) and coronary artery disease (rg-0.30, P =6.5x10-9) and, in large cohort data sets, demonstrated that genetic factors were the major contributor to the negative covariance between BW and future cardiometabolic risk. Pathway analyses indicated that the protein products of genes within BW-associated regions were enriched for diverse processes including insulin signalling, glucose homeostasis, glycogen biosynthesis and chromatin remodelling. There was also enrichment of associations with BW in known imprinted regions (P =1.9x10-4). We have demonstrated that lifecourse associations between early growth phenotypes and adult cardiometabolic disease are in part the result of shared genetic effects and have highlighted some of the pathways through which these causal genetic effects are mediated
Genome-wide associations for birth weight and correlations with adult disease
Birth weight (BW) has been shown to be influenced by both fetal and maternal factors and in observational studies is reproducibly associated with future risk of adult metabolic diseases including type 2 diabetes (T2D) and cardiovascular disease. These life-course associations have often been attributed to the impact of an adverse early life environment. Here, we performed a multi-ancestry genome-wide association study (GWAS) meta-analysis of BW in 153,781 individuals, identifying 60 loci where fetal genotype was associated with BW ( < 5 × 10). Overall, approximately 15% of variance in BW was captured by assays of fetal genetic variation. Using genetic association alone, we found strong inverse genetic correlations between BW and systolic blood pressure ( = -0.22, = 5.5 × 10), T2D ( = -0.27, = 1.1 × 10) and coronary artery disease ( = -0.30, = 6.5 × 10). In addition, using large -cohort datasets, we demonstrated that genetic factors were the major contributor to the negative covariance between BW and future cardiometabolic risk. Pathway analyses indicated that the protein products of genes within BW-associated regions were enriched for diverse processes including insulin signalling, glucose homeostasis, glycogen biosynthesis and chromatin remodelling. There was also enrichment of associations with BW in known imprinted regions ( = 1.9 × 10). We demonstrate that life-course associations between early growth phenotypes and adult cardiometabolic disease are in part the result of shared genetic effects and identify some of the pathways through which these causal genetic effects are mediated.For a full list of the funders pelase visit the publisher's website and look at the supplemetary material provided. Some of the funders are: British Heart Foundation, Cancer Research UK, Medical Research Council, National Institutes of Health, Royal Society and Wellcome Trust
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
Birth weight variation is influenced by fetal and maternal genetic and non-genetic factors, and has been reproducibly associated with future cardio-metabolic health outcomes. In expanded genome-wide association analyses of own birth weight (n = 321,223) and offspring birth weight (n = 230,069 mothers), we identified 190 independent association signals (129 of which are novel). We used structural equation modeling to decompose the contributions of direct fetal and indirect maternal genetic effects, then applied Mendelian randomization to illuminate causal pathways. For example, both indirect maternal and direct fetal genetic effects drive the observational relationship between lower birth weight and higher later blood pressure: maternal blood pressure-raising alleles reduce offspring birth weight, but only direct fetal effects of these alleles, once inherited, increase later offspring blood pressure. Using maternal birth weight-lowering genotypes to proxy for an adverse intrauterine environment provided no evidence that it causally raises offspring blood pressure, indicating that the inverse birth weight-blood pressure association is attributable to genetic effects, and not to intrauterine programming.The Fenland Study is funded by the Medical Research Council (MC_U106179471) and
Wellcome Trust
E-cigaretter:en gevinst for folkesundheden eller endnu en udfordring i tobaksforebyggelsen?
The relationship between lifestyle and self-reported health in a general population: the Inter99 study
International Approaches to Tobacco Use Cessation Programs and Policy in Adolescents and Young Adults: Denmark
Our healthy community - development of a new model for health promotion and disease prevention in Danish municipalities
BACKGROUND: The Danish health care system is facing major challenges as the prevalence of chronic diseases increases. There is a need for new approaches and strategies to prevent chronic disease and promote health and well-being among citizens. The aim is to describe the development of a new model for coordinated, integrated and evidence-based health promotion and disease prevention in Danish municipalities. The model builds on the supersetting approach, intersectoral collaboration and community engagement and applies a broad bio-psychosocial concept of health. METHODS: Two Danish municipalities were included in the initial development and testing of the model from 2019 to 2021. This involved the following steps in each municipality: 1) Analyzing the health status, lifestyles and socio-economy at municipality level. 2) Mobilizing lead municipal administrators and politicians for intersectoral action including jointly defining thematic focus areas and target populations. 3) Mapping community-based stakeholders, physical environments and existing evidence to qualify relevant action 4) Mobilizing professional stakeholders from the public, private and civic sectors for co-creation of intervention ideas and joint action. 5) Co-creating and implementing interventions together with professional stakeholders and citizens. RESULTS: The strategic model and results from the development process will be presented from one of the involved municipalities: The municipal administration chose physical activity and well-being among children and young people as their key focus area. Community-based stakeholders from non-profit organizations and public institutions, including sports clubs, leisure clubs, primary schools, and public departments jointly developed and implemented specific interventions. One specific intervention aimed to engage more children in local clubs. Coaches from three local sport clubs introduced 1st and 4th grade students at two schools to their sport (a course of eight times) during students' time in their local after-school club. Overall, the process fostered broad engagement of stakeholders from the public sector, the private sector, and civil society. CONCLUSION: The model developed in Our Healthy Community builds on contextual analyses, dialogues, workshops, and co-creation processes with a wide range of stakeholders to promote local relevance, integration and sustainability of developed actions and interventions. The model will be pilot tested in two other Danish municipalities (2022-2025